日本国际医疗展2022MEDICAL JAPAN|医疗设备器械装置展品

机构点对点扶持，促进创新药物的快速有效开发：国立研究开发法人日本医疗研究开发机构（AMED）设立“创药战略部”主导，在国家战略特区内临床研究的核心医院设置定点协调者，提供关于强化出口战略、知识产权战略等各类问题咨询的窗口功能，促进创新药物的实用化。“创药战略部”还负责：基础和应用研究战略的制定和建议；共同研究机构和试验实施机构的介绍

Point-to-pointsupport from professional institutions to promote the rapid andeffective development of innovative drugs: The National Researchand Development Corporation Japan Medical Research and DevelopmentAgency (AMED) established the "Innovative Drug Strategy Department"to lead the establishment of designated coordinators in the corehospitals for clinical research in the national strategic specialzone, providing Regarding strengthening the window function forconsultation on various issues such as export strategy andintellectual property strategy, and promote the practicalapplication of innovative drugs. At the same time, the "InnovativeDrug Strategy Department" is also responsible for: formulation andrecommendations of basic and applied research strategies;introduction of joint research institutions and trialimplementation institutions